Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
---|
08/22/2001 | EP1124797A1 N-arylsulfonyl amino acid omega amides |
08/22/2001 | EP1071661A4 Process for preparing 4-hydroxy indole, indazole and carbazole compounds |
08/22/2001 | CN1309637A Compositions comprising 2-phenyl-indole compounds and estrogen formutations |
08/22/2001 | CN1309634A Hydrazine derivs. |
08/22/2001 | CN1309325A Photographic element, compound and method |
08/21/2001 | US6277992 Useful as an intermediate for preparing camptothecin derivatives having antitumor activities |
08/21/2001 | US6277987 Sulfonylamino acid and sulfonylamino hydroxamic acid derivatives |
08/21/2001 | US6277897 Photoinitiators and applications therefor |
08/21/2001 | US6277878 Substituted indole compounds as anti-inflammatory and analgesic agents |
08/21/2001 | US6277877 Substituted n-(indole-2-carbonyl)glycinamides and derivates as glycogen phosphorylase inhibitors |
08/21/2001 | US6277876 Antiinflammatory agents; prevent tissue degradation |
08/21/2001 | US6277872 Antiischemic agents; brain disorders |
08/21/2001 | US6277870 Use |
08/21/2001 | US6277865 Anticoagulants |
08/21/2001 | US6277849 N-sulphonyl and N-sulphinyl amino acid amides as microbiocides |
08/21/2001 | US6277847 Herbicidal isoindolinonyl-and 3,4-dihydroisoquinolonyl-substituted heterocycles |
08/21/2001 | US6277833 3-hydroxy-3-methyl-glutaryl coenzyme a (hgm--coa) reductase inhibitors which retard cholesterol biosynthesis |
08/21/2001 | CA2319308C Pharmaceutical agents |
08/21/2001 | CA2060652C N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives |
08/16/2001 | WO2001058893A2 Indol-3-yl derivatives and their use as integrin inhibitors |
08/16/2001 | WO2001058891A2 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage |
08/16/2001 | WO2001058870A2 Solid-phase process for making indole compounds |
08/16/2001 | WO2001058869A2 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
08/16/2001 | WO2001058868A1 Method for synthesis of perindopril and its pharmaceutically acceptable salts |
08/16/2001 | WO2001058853A1 Dehydroamino acids |
08/16/2001 | WO2001058852A2 (r)-2-aryl-propionamides, useful in the inhibition of il-8-induced chemiotaxis of neutrophils |
08/16/2001 | WO2001058843A1 Process for preparing optically active secondary alcohols having nitrogenous or oxygenic functional groups |
08/16/2001 | WO2001058471A2 Novel amino acid and peptide inhibitors of staphylococcus virulence |
08/16/2001 | WO2001010842A3 Melanocortin-4 receptor binding compounds and methods of use thereof |
08/16/2001 | WO2001009096A3 Potassium channel openers |
08/16/2001 | WO2001007435A3 N-(indolcarbonyl-)piperazin derivatives als 5-ht2a-receptor ligands |
08/16/2001 | US20010014740 Method of producing heterocyclic derivatives |
08/16/2001 | US20010014695 Therapy for degradation diseases; oxidation resistance |
08/16/2001 | US20010014690 Substituted N-benzylindol-3-ylglyoxylic acid derivatives having antitumor action |
08/16/2001 | US20010014677 Restenosis, kidney diseases, lung diseases |
08/16/2001 | EP1123922A2 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
08/16/2001 | EP1123918A1 Aromatic amine derivatives, process for the preparation thereof and agents containing the same |
08/16/2001 | EP1123279A1 New compounds, their preparation and use |
08/16/2001 | EP1123278A1 Method for producing (+)-exo-6-phenyl-3-azabicyclo- 3.2.0]heptanes |
08/16/2001 | EP1123277A1 Epibatidine analogues as acetylcholine receptor antagonists |
08/16/2001 | EP1123272A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
08/16/2001 | EP0882033B1 Benzofuran-acrylic acid derivatives and their use as modulators of rxrs or rars receptors |
08/16/2001 | EP0684820B1 Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents |
08/16/2001 | EP0677050B1 Novel pyridone carboxylic acid derivatives |
08/16/2001 | EP0558677B1 Biologically active amines |
08/16/2001 | DE10006139A1 Indol-3-yl-Derivate Indol-3-yl derivatives |
08/16/2001 | CA2399791A1 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
08/16/2001 | CA2398822A1 Piperazine and piperidine derivatives |
08/16/2001 | CA2397993A1 Dehydroamino acids |
08/15/2001 | CN1308630A Benzocarbazole and indenoindole derived estrogenic agents |
08/15/2001 | CN1308626A Benzothiophenes, benzofurans, and indoles useful in the treatment of insulin resistance and hyperglycemia |
08/15/2001 | CN1308625A Naphtho [2,3-b] heteroar-4-yl derivatives |
08/15/2001 | CN1308608A Substituted beta-amino acid inhibitors of methionine aminopeptidase-2 |
08/15/2001 | CN1308606A Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use pharmaceutical preparations comprising them |
08/15/2001 | CN1308604A 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
08/15/2001 | CN1308542A Sucoinamide inhibitors of interleukin-1& beta, converting enzyme |
08/15/2001 | CN1308532A Mycobacterial inhibitors |
08/15/2001 | CN1308251A Photographic element, compound and method containing azacyclo-substrated color former |
08/15/2001 | CN1308056A Heterocyclic benzonitrile |
08/14/2001 | US6274757 Neuromuscular relaxants |
08/14/2001 | US6274623 Neuromuscular relaxants |
08/14/2001 | US6274616 ((3-(2-amino-1,2-dioxoethyl)-1-((1,1'-biphenyl)-3-ylmethyl)-2 -methyl-1h-indol-4-yl)oxy)acetic acid n,n-diethylglycolamidoester used for inhibiting human non-pancreatic secretory phopholipase a2 mediated release of |
08/14/2001 | US6274578 sPLA2 inhibitor ester |
08/14/2001 | CA2226406C Novel pyridone carboxylic acid derivatives |
08/14/2001 | CA2159640C Second messenger cell signaling inhibitors |
08/14/2001 | CA2029265C 4- and 6-carbamates related to physostigmine, a process and intermediates for their preparation and their use as medicaments |
08/09/2001 | WO2001057526A1 Method for analysis of reaction products |
08/09/2001 | WO2001056988A1 Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same |
08/09/2001 | WO2001056974A2 Inha inhibitors and their use as antibacterials |
08/09/2001 | WO2001056607A1 Integrin expression inhibitors |
08/09/2001 | WO2001056560A1 Substituted amino acids as neutral sphingomyelinase inhibitors |
08/09/2001 | WO2001056555A2 Use of cox-2 inhibitors for the treatment of constipation |
08/09/2001 | WO2001056353A2 Novel method for synthesis of n-[(s)-1-carboxybutyl]-(s)-alanine esters and use in synthesis of perindopril |
08/09/2001 | WO2001010834A9 Antibacterial agents |
08/09/2001 | US20010012895 Therapy for hair loss in mammals; drug resistance; nervous system disorders |
08/09/2001 | US20010012857 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
08/09/2001 | US20010012854 Administering to the patient a diamide compound to induce apoptosis in tumor cells |
08/09/2001 | US20010012851 A carbamate, carbonate or carboxasulfide containing oxindole compound used for treating osteroarthritis, an inflammatory disease or degenerative joint disease without causing side effect |
08/09/2001 | US20010012844 Quinazoline, nitrothiazole and indolinone based hydrophobic formulations for oral administration for treating cell proliferation disorder in a mammal |
08/09/2001 | US20010012596 Oxime ester photoinitiators |
08/09/2001 | CA2399792A1 Substituted amino acids as neutral sphingomyelinase inhibitors |
08/08/2001 | EP1121108A2 Novel therapeutic use of compounds with beta-3-agonist activity |
08/08/2001 | CN1307575A New hydroxyindoles, their use as phosphodiesterase 4 inhibitors and method for producing same |
08/08/2001 | CN1307574A Indolyl derivatives as serotonergic agents |
08/08/2001 | CN1307564A Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them |
08/08/2001 | CN1307562A Antipsychotic indolyl derivatives |
08/08/2001 | CN1069314C 2-oxoindoline derivative |
08/08/2001 | CN1069309C N-(aminopropyl)-N-phenyl-5,6,7,8-tetrahydronaphtalene-2-carboxamide derivative, preparation and application thereof |
08/07/2001 | US6271390 Suppression of the IgE-dependent allergic response by benzimidazole analogs |
08/07/2001 | US6271357 Oligonucleotide mimics having nitrogen-containing linkages |
08/07/2001 | US6271247 Binding to neuropeptide receptors |
08/07/2001 | US6271235 HIV protease inhibitors |
08/07/2001 | US6271195 Aminimide-containing molecules and materials as molecular recognition agents |
08/07/2001 | US6271180 Substituted phenyl keto enols as pesticides and herbicides |
08/07/2001 | CA2030051C Indole derivatives |
08/02/2001 | WO2001055130A2 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vasopressin receptors |
08/02/2001 | WO2001055111A1 Biaryl compounds, their preparation and their use in therapy |
08/02/2001 | WO2001055110A1 Isatine derivatives with neurotrophic activity |
08/02/2001 | WO2001055109A1 Aromatic amides acting on melanocortin receptors |
08/02/2001 | WO2001055107A2 Aromatic amines and amides acting on the melanocortin receptors |